JNJ000242147
Metadata
BegAttach
Confidentiality
Custodian
DocumentType
EndAttach
PgCount
Text Path
Trial_Ex_Number

JNJ 000242147
Y
Legacy 1
Physical
JNJ 000242147
1
TEXT\0238\JNJ 000242147.txt
Pltf_JNJ_00031883

ORIGINAL
ORIGINAL
ORIGINAL
ORIGINAL
ORIGINAL
ORIGINAL
ORIGINAL
ORIGINAL

 . as 



BABYPRODUCTSCOMPANY

.711 Jv?uw-

RARITAN, NJ. 08869

November 24, 1976
TO: 'Mr. George Lee

Attached is a copy of a disturbing proposal request which
the FDA has-currently made available to qualified bidders. The
scope of the work is the Separation of Asbestos in Foods, Drugs
and Talc for Identification and Determination. 

I find this proposal more disturbing than other proposals

up to now because it aims at separation and isolation of asbestos
f1om a wide scope of products and animal tissues. Up to now, our
ma.1n problems have had to do with identification, whereas, now it
looks like the FDA is getting into separation and isolation method-
.ology which will mean concentration procedures. As I have pointed
out many times, there are many talcs on all markets which will be
hard pressed in supporting purity claims, when ultra sophisticated
assay separation and isolation techniques are applied. Chances are
that this FDA proposal will open up new problem areas with asbestos
and talc minerals

 

I intend to keep tuned into the matter through my outside mineral
friends who called the thing to my attention while I was at a fiber
meeting in Montreal, November 8th and 9th. 



. H. Ashton
Attachment - - . g) 

WHAzblb

ccz' Dr. D. R.?Petterson, no attache
Dr. B. Semple, no attach.

Protected Document--Subject to Protective Order JNJ 000242147

1 of 1 
JNJ000242147